Chroma Therapeutics raised a round of funding on , . Investors include Abingworth.
Chroma Therapeutics is a biotechnology company founded to exploit the potential of chromatin biology for cancer drug discovery. Chroma is focused on the identification of anti-cancer agents that combi…
